Heru, which is building a tool that uses AI and commercial AR/VR headsets to diagnose eye conditions and vision loss, raises $30M Series A led by D1 Capital (Conor Hale/FierceBiotech)

Conor Hale / FierceBiotech:
Heru, which is building a tool that uses AI and commercial AR/VR headsets to diagnose eye conditions and vision loss, raises $30M Series A led by D1 Capital  —  The classic eye chart wall poster is getting an upgrade, with newcomer Heru looking to bring vision tests into virtual reality.